2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow COPD Exacerbation Acute: new trials by email Literature Review of COPD Exacerbation Acute trials Research Report on COPD Exacerbation Acute
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection Vapendavir, Placebo - COPD Exacerbation Acute, COPD With Acute Lower Respiratory Infection | Phase 2 | Completed | Altesa Biosciences, Inc. | 52 | 2023-11-20 | 2025-09-30 |
| Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD Beta-Lactams, Fluoroquinolone - COPD Exacerbation Acute | Phase 2 / Phase 3 | Completed | Haiphong University of Medicine and Pharmacy | 170 | 2020-01-01 | 2021-05-10 |
Common Cold (1) · Emphysema (1) · Enterovirus Infections (1) · Infections (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pulmonary Disease, Chronic Obstructive (1) · RNA Virus Infections (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Chronic Disease (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Picornaviridae Infections (1)
Cefixime (1) · Cefotaxime (1) · Ceftazidime (1) · Ceftriaxone (1) · Ciprofloxacin (1) · Ertapenem (1) · Fluoroquinolones (1) · Levofloxacin (1) · Meropenem (1) · Moxifloxacin (1) · Piperacillin, Tazobactam Drug Combination (1) · beta-Lactams (1) · ticarcillin-clavulanic acid (1)
Altesa Biosciences, Inc. (1) · Haiphong University of Medicine and Pharmacy (1)
United Kingdom (1) · Vietnam (1)
Onn Min Kon, MD (1) · Phuong TT Nguyen, PhD MD (1)